[68Ga]PSMA
- Generic Name
- [68Ga]PSMA
A Study of 68Gallium PSMA-PET/CT Scans in People With Bladder Cancer or Skin Cancer
Phase 1
Recruiting
- Conditions
- Bladder Cancer
- Interventions
- Diagnostic Test: PET/CT imaging
- First Posted Date
- 2022-10-03
- Last Posted Date
- 2024-12-31
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 20
- Registration Number
- NCT05562791
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Digital PET/CT Using [Ga-68]PSMA vs. [F-18]NaF for Evaluation of Osseous Metastatic Involvement in Prostate Cancer Patients
Completed
- Conditions
- Prostate Cancer
- Interventions
- First Posted Date
- 2022-09-02
- Last Posted Date
- 2024-05-16
- Lead Sponsor
- University Hospitals Cleveland Medical Center
- Target Recruit Count
- 32
- Registration Number
- NCT05527483
- Locations
- 🇺🇸
Case Comprehensive Cancer Center, Cleveland, Ohio, United States
Digital PET/CT Using [Ga-68]PSMA for Characterization of Prostate Lesions
- First Posted Date
- 2021-04-30
- Last Posted Date
- 2023-12-19
- Lead Sponsor
- Norbert Avril, M.D.
- Target Recruit Count
- 16
- Registration Number
- NCT04867603
- Locations
- 🇺🇸
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath